Lineage Cell Therapeutics Inc (AMEX:LCTX) price is hovering higher on Wednesday, April 17, jumping 6.52% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $1.15. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.61 and 52-week low of $0.84. The stock added 4.70% on its value in the past month.
Lineage Cell Therapeutics Inc, which has a market valuation of $230.95 million. Analysts tracking LCTX have forecast the quarterly EPS to shrink by -0.04 per share this quarter, while the same analysts predict the annual EPS to hit -$0.11 for the year 2024 and up to -$0.13 for 2025. In this case, analysts estimate an annual EPS growth of 8.30% for the year and -18.20% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $1.36 million, with the likely lows of -$ and highs of $3.59 million. The average estimate suggests sales growth for the quarter will likely fall by -32.30% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $17.48 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow 95.40% above that which the company brought in 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give LCTX a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that LCTX’s price is at present -8.99% off the SMA20 and 1.44% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 45.95, with weekly volatility standing at 8.99%. The indicator jumps to 9.33% when calculated based on the past 30 days. Lineage Cell Therapeutics Inc (AMEX:LCTX)’s beta value is holding at 1.38, while the average true range (ATR) indicator is currently reading 0.12.
An analysis of the Lineage Cell Therapeutics Inc (AMEX:LCTX) stock in terms of its daily trading volume indicates that the 3-month average is 918.56K.
Current records show that the company has 188.53M in outstanding shares. The insiders’ percentage holdings are 0.55% of outstanding shares while the percentage share held by institutions stands at 48.04%. But the 12.39% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
